Dawaa Reference

chronic

Fibrocystic breast disease

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Fibrocystic Breast Disease - StatPearls - NCBI Bookshelf (NBK551609) - https://www.ncbi.nlm.nih.gov/books/NBK551609/ · ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class GD67 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (4)

  • Benign cysts move freely under the skin and feel rubbery, with little or no discomfort except in the inflamed type [cyst]
  • Multiple cysts, rather than a single one, are the usual finding on full work-up [cyst]
  • A fibroadenoma feels like a mobile, oval, well-defined lump and often occurs as more than one [breast lump]
  • Nipple discharge can come from duct ectasia or an intraductal papilloma, and rarely from cancer [nipple discharge]

Signs — what you find (2)

  • A single-duct, sudden, bloody discharge with a small palpable lump near the areola points to an intraductal papilloma; a multi-duct, non-spontaneous, multicolored discharge points to duct ectasia [skin nodule]
  • Cyst-related lumps are commonly found in the upper outer part and central area of the breast, ranging from firm to several sub-centimeter cysts on exam [cyst]

Tests (6)

  • Any discrete palpable lump needs the full triple assessment - clinical exam, imaging, and biopsy - in every woman
  • In women under 30, nodularity can often be watched with a short-interval repeat exam in 2 to 3 months rather than immediate imaging
  • Asymmetric nodularity in a woman over 30 warrants mammography plus ultrasound
  • A discrete lump in a woman over 35 needs mammography with ultrasound to tell a cyst from a solid mass, and a mixed fluid-and-solid cyst needs biopsy
  • Fine-needle aspiration fails to yield enough material for a diagnosis in 35 to 47 percent of non-palpable lumps, so a core biopsy is then advised
  • When clinical exam and imaging are both benign, a repeat clinical exam, ultrasound, and mammography at 6 to 12 months confirms things are stable

If not this — what else fits (3)

  • A breast abscess or other infection can also present as a lump
  • Trauma or fat necrosis can produce a similar breast finding
  • A papilloma or a phyllodes tumor is also on the differential

SourceStatPearls "Fibrocystic Breast Disease" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Fibrocystic breast changes are a common benign cause of breast pain and lumpiness; the GP reassures, offers simple analgesia, and refers any new discrete or dominant lump for imaging to exclude malignancy. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Fibrocystic breast changes are a common benign cause of breast pain and lumpiness; the GP reassures, offers simple analgesia, and refers any new discrete or dominant lump for imaging to exclude malignancy.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - A new discrete dominant lump distinct from the background lumpiness, skin dimpling or nipple retraction, or blood-stained nipple discharge: refer.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.